INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, will be showcased in three presentations, including new Phase 1 monotherapy and combination data in ...
Jasper Therapeutics, Inc. announced that four abstracts highlighting the clinical progress of briquilimab, an antibody therapy targeting c-Kit for mast cell-driven diseases, will be presented at the ...
Contributions on the topics listed in the Conference Announcement under Section C are welcome as oral or poster presentations. All submissions, apart from invited papers, must present original work, ...
WILMINGTON, Del., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (PRLD) (“Prelude” or the “Company”), a clinical-stage precision oncology company, today announced the publication ...
Opus Genetics, Inc. announced that three abstracts concerning its investigational gene therapy candidates will be presented at the ARVO 2025 Meeting in Salt Lake City, UT, from May 4-8, 2025. The ...
Computer Security’s Place in the Nuclear Sector and Beyond Regulatory Frameworks Capacity & Competency Management for Computer Security and Sustainability Threats and Risks Computer Security by Design ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback